Matthias Wittstock
Overview
Explore the profile of Matthias Wittstock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
915
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Krzywicka K, Aguiar de Sousa D, Cordonnier C, Bode F, Field T, Michalski D, et al.
Eur J Neurol
. 2023 Feb;
30(5):1335-1345.
PMID: 36773014
Background And Purpose: Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. CVST-VITT...
12.
van de Munckhof A, Lindgren E, Kleinig T, Field T, Cordonnier C, Krzywicka K, et al.
Stroke
. 2022 Sep;
53(10):3206-3210.
PMID: 36082668
Background: Cerebral venous thrombosis (CVT) due to vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe condition, with high in-hospital mortality rates. Here, we report clinical outcomes of patients with CVT-VITT...
13.
Dimitriadis K, Meis J, Neugebauer H, Barlinn K, Neumann B, Gahn G, et al.
Crit Care
. 2022 Jul;
26(1):217.
PMID: 35842675
Background: Neurologic manifestations are increasingly reported in patients with coronavirus disease 2019 (COVID-19). Yet, data on prevalence, predictors and relevance for outcome of neurological manifestations in patients requiring intensive care...
14.
Scutelnic A, Krzywicka K, Mbroh J, van de Munckhof A, Sanchez van Kammen M, Aguiar de Sousa D, et al.
Ann Neurol
. 2022 Jun;
92(4):562-573.
PMID: 35689346
Objective: Cerebral venous thrombosis (CVT) caused by vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus-based severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccines. In March 2021, after...
15.
Horn A, Reich M, Ewert S, Li N, Al-Fatly B, Lange F, et al.
Proc Natl Acad Sci U S A
. 2022 Mar;
119(14):e2114985119.
PMID: 35357970
Dystonia is a debilitating disease with few treatment options. One effective option is deep brain stimulation (DBS) to the internal pallidum. While cervical and generalized forms of isolated dystonia have...
16.
Volk S, Pfirrmann M, Koedel U, Pfister H, Lang T, Scheibe F, et al.
J Neurol
. 2022 Mar;
269(7):3389-3399.
PMID: 35316388
Background And Objectives: In 2020, a wide range of hygiene measures was implemented to mitigate infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In consequence, pulmonary infections...
17.
Wittstock M, Kastner M, Kolbaske S, Sellmann T, Porath K, Patejdl R
Front Nutr
. 2022 Feb;
8:742656.
PMID: 35187015
Delayed gastric emptying contributes to complications as aspiration or malnutrition. Among patients suffering from acute neurological diseases, motility disorders are prevalent but poorly understood. Thus, methods to measure gastric emptying...
18.
Wittstock M, Walter U, Volmer E, Storch A, Weber M, Grossmann A
Neuroradiology
. 2022 Feb;
64(5):865-874.
PMID: 35184205
Cerebral venous and sinus thrombosis (CVST) after adenovirus-vectored COVID-19 ChAdOx1 nCov-19 (Oxford-AstraZeneca) and Ad26.COV2.S (Janssen/Johnson & Johnson) is a rare complication, occurring mainly in individuals under 60 years of age...
19.
Schmidbauer M, Ferse C, Salih F, Klingner C, Musleh R, Kunst S, et al.
J Clin Med
. 2022 Feb;
11(3).
PMID: 35160057
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) profoundly impacts hemostasis and microvasculature. In the light of the dilemma between thromboembolic and hemorrhagic complications, in the present paper, we systematically...
20.
Sanchez van Kammen M, Aguiar de Sousa D, Poli S, Cordonnier C, Heldner M, van de Munckhof A, et al.
JAMA Neurol
. 2021 Sep;
78(11):1314-1323.
PMID: 34581763
Importance: Thrombosis with thrombocytopenia syndrome (TTS) has been reported after vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and Ad26.COV2.S (Janssen/Johnson & Johnson). Objective: To describe the clinical characteristics and...